Anti-TNFα therapy in inflammatory lung diseases
Top Cited Papers
- 1 December 2017
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 180, 90-98
- https://doi.org/10.1016/j.pharmthera.2017.06.008
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (U54AR055073, R01ES004738, P30ES005022)
This publication has 149 references indexed in Scilit:
- Selective inhibition of intra-alveolar p55 TNF receptor attenuates ventilator-induced lung injuryThorax, 2011
- Sulfur mustard-induced pulmonary injury: Therapeutic approaches to mitigating toxicityPulmonary Pharmacology & Therapeutics, 2011
- Role of TNFR1 in lung injury and altered lung function induced by the model sulfur mustard vesicant, 2-chloroethyl ethyl sulfideToxicology and Applied Pharmacology, 2011
- Inflammatory effects of inhaled sulfur mustard in rat lungToxicology and Applied Pharmacology, 2010
- Transmembrane TNF- : structure, function and interaction with anti-TNF agentsRheumatology, 2010
- Regulation of caveolin-1 expression, nitric oxide production and tissue injury by tumor necrosis factor-α following ozone inhalationToxicology and Applied Pharmacology, 2008
- Signal Transduction Pathways of Tumor Necrosis Factor–mediated Lung Injury Induced by Ozone in MiceAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Soluble TNF Mediates the Transition from Pulmonary Inflammation to FibrosisPLOS ONE, 2006
- Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injuryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- Tumour necrosis factor‐α: The role of this multifunctional cytokine in asthmaImmunology & Cell Biology, 2001